Status:
TERMINATED
French Post-Marketing Surveillance Survey
Lead Sponsor:
Cordis US Corp.
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To assess the safety and effecacy of the Cypher stent ™ \& Cypher Select ™ in the normal use of medical practices, within the labeled indications.
Detailed Description
Multi-center, retrospective and prospective French register. This register does not impose any constraint on the evaluated population, the procedure, or the required examinations. The local practice r...
Eligibility Criteria
Inclusion
- Patients with symptomatic ischemic heart disease due to de novo lesions (lesions \<30 mm vessel reference diameter of 2.25 mm to 5 mm), assessed visually, native coronary arteries.
Exclusion
- Patients suffering from coronary heart disease.
- Patients for whom treatment antiplatelet and / or anticoagulant is against the state;
- Patients with injuries incompatible with the full inflation of a balloon angioplasty;
- Transplant patients ;
- Patients with known allergy to Sirolimus, the stainless steel 316L, to polymethacrylates or copolymers polyolefins;
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
4080 Patients enrolled
Trial Details
Trial ID
NCT00855478
Start Date
May 1 2006
End Date
September 1 2008
Last Update
November 29 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.